William J. Holloway

804 total citations
29 papers, 581 citations indexed

About

William J. Holloway is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, William J. Holloway has authored 29 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Pharmacology. Recurrent topics in William J. Holloway's work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Antifungal resistance and susceptibility (5 papers). William J. Holloway is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Antifungal resistance and susceptibility (5 papers). William J. Holloway collaborates with scholars based in United States and Spain. William J. Holloway's co-authors include Lynn Steele‐Moore, Darwin L. Palmer, Ronald W. Geckler, Clair E. Cox, Jesús Gómez‐Mateos, Ana Isabel Aller, M. J. Gutiérrez, Fernando Lozano, F Recio and Ana Espinel-Ingroff and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

William J. Holloway

28 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William J. Holloway United States 13 318 299 112 82 74 29 581
A. M. Clarke Canada 14 205 0.6× 166 0.6× 166 1.5× 138 1.7× 47 0.6× 30 566
J.H. Andrew Australia 13 173 0.5× 266 0.9× 52 0.5× 67 0.8× 61 0.8× 37 578
M. Ridley United Kingdom 11 159 0.5× 212 0.7× 45 0.4× 45 0.5× 67 0.9× 18 488
H.A. Verbrugh Netherlands 10 183 0.6× 165 0.6× 95 0.8× 52 0.6× 28 0.4× 20 458
M S Simberkoff United States 8 282 0.9× 209 0.7× 123 1.1× 60 0.7× 27 0.4× 8 470
Morton Hamburger United States 14 301 0.9× 244 0.8× 70 0.6× 48 0.6× 31 0.4× 59 588
Geraci Je 13 343 1.1× 308 1.0× 122 1.1× 42 0.5× 41 0.6× 36 661
A Iravani United States 12 379 1.2× 94 0.3× 124 1.1× 95 1.2× 48 0.6× 35 575
Birgitta Henriques Sweden 9 479 1.5× 254 0.8× 58 0.5× 77 0.9× 194 2.6× 11 715
Nobuchika Kusano Japan 13 304 1.0× 120 0.4× 71 0.6× 82 1.0× 60 0.8× 57 534

Countries citing papers authored by William J. Holloway

Since Specialization
Citations

This map shows the geographic impact of William J. Holloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Holloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Holloway more than expected).

Fields of papers citing papers by William J. Holloway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Holloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Holloway. The network helps show where William J. Holloway may publish in the future.

Co-authorship network of co-authors of William J. Holloway

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Holloway. A scholar is included among the top collaborators of William J. Holloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Holloway. William J. Holloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vázquez, José A., Grace Peng, Jack D. Sobel, et al.. (2001). Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis. Clinical Infectious Diseases. 33(7). 1069–1075. 45 indexed citations
2.
Aller, Ana Isabel, Estrella Martín‐Mazuelos, Fernando Lozano, et al.. (2000). Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection. Antimicrobial Agents and Chemotherapy. 44(6). 1544–1548. 127 indexed citations
3.
Vázquez, Federico, Jack D. Sobel, Grace Peng, et al.. (1999). Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?. Clinical Infectious Diseases. 28(5). 1025–1031. 40 indexed citations
4.
5.
Holloway, William J. & Darwin L. Palmer. (1996). Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections. The American Journal of Medicine. 100(6). 52S–59S. 40 indexed citations
6.
Schwalbe, Ruth A., Sadaf Qaiyumi, J A Johnson, et al.. (1996). In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrobial Agents and Chemotherapy. 40(10). 2416–2419. 61 indexed citations
7.
Cox, Clair E., William J. Holloway, & Ronald W. Geckler. (1995). A Multicenter Comparative Study of Meropenem and Imipenem/Cilastatin in the Treatment of Complicated Urinary Tract Infections in Hospitalized Patients. Clinical Infectious Diseases. 21(1). 86–92. 46 indexed citations
8.
McGrath, Stephanie, et al.. (1991). In vitro synergy studies with Clostridium difficile. Antimicrobial Agents and Chemotherapy. 35(3). 582–583. 13 indexed citations
9.
Reinhardt, John F., et al.. (1989). Brief report: Ciprofloxacin versus ceftazidime in serious infections. The American Journal of Medicine. 87(5). S181–S182. 1 indexed citations
10.
Holloway, William J., Dean L. Winslow, & J. F. Reinhardt. (1989). Cefmetazole treatment of intra-abdominal infection. Journal of Antimicrobial Chemotherapy. 23(suppl D). 47–54. 15 indexed citations
11.
Holloway, William J. & John F. Reinhardt. (1986). Infectious Disease Emergencies. Primary Care Clinics in Office Practice. 13(1). 119–134. 4 indexed citations
12.
Holloway, William J.. (1986). Management of sepsis in the elderly. The American Journal of Medicine. 80(6). 143–148. 18 indexed citations
13.
Holloway, William J.. (1982). Spectinomyein. Medical Clinics of North America. 66(1). 169–173. 9 indexed citations
14.
Holloway, William J.. (1975). Clindamycin-Associated Colitis. Southern Medical Journal. 68(12). 1469–1470. 1 indexed citations
15.
Holloway, William J. & William A. Taylor. (1973). Long-Term Oral Carbenicillin Therapy in Complicated Urinary-Tract Infections. The Journal of Infectious Diseases. 127(Supplement 2). S143–S147. 1 indexed citations
16.
Holloway, William J.. (1971). Infectious disease reviews. 10 indexed citations
17.
Holloway, William J., et al.. (1969). Carbenicillin in the treatment of severe infections.. PubMed. 11(4). 143–9. 3 indexed citations
18.
Nelson, Dewey A., et al.. (1967). Neurological syndromes produced by sphenoid sinus abscess With neuroradiologic review of pituitary abscess. Neurology. 17(10). 981–981. 25 indexed citations
19.
Holloway, William J., et al.. (1965). CLINICAL EXPERIENCE WITH LINCOMYCIN. The American Journal of the Medical Sciences. 249(6). 691–695. 14 indexed citations
20.
Holloway, William J., et al.. (1963). LINCOMYCIN: A CLINICAL STUDY.. PubMed. 161. 200–3. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Clarke Breakdown of academic impact, for papers by J.H. Andrew Breakdown of academic impact, for papers by M. Ridley Breakdown of academic impact, for papers by H.A. Verbrugh Breakdown of academic impact, for papers by M S Simberkoff Breakdown of academic impact, for papers by Morton Hamburger Breakdown of academic impact, for papers by Geraci Je Breakdown of academic impact, for papers by A Iravani Breakdown of academic impact, for papers by Birgitta Henriques Breakdown of academic impact, for papers by Nobuchika Kusano
Rankless by CCL
2026